Ident. | Authors (with country if any) | Title |
---|
000183 (2011) |
Masayuki Watanabe [Japon, Canada] ; Douglas P. Munoz [Canada] | Probing basal ganglia functions by saccade eye movements |
000229 (2011) |
Yuen-Sum Lau [États-Unis] ; Gaurav Patki [États-Unis] ; Kaberi Das-Panja [États-Unis] ; Wei-Dong Le [États-Unis] ; S. Omar Ahmad [États-Unis] | Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration |
000231 (2011) |
Beate Winner [États-Unis, Allemagne] ; Zacharias Kohl [Allemagne] ; Fred H. Gage [États-Unis] | Neurodegenerative disease and adult neurogenesis |
000284 (2011) |
Maria Papathanou [Suède] ; Sarah Rose [Royaume-Uni] ; Andrew Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni] | Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6‐OHDA‐lesioned rats |
000289 (2011) |
Guadalupe Soria [Espagne] ; Esther Aguilar [Espagne] ; Raúl Tudela [Espagne] ; Joaquim Mullol [Espagne] ; Anna M. Planas [Espagne] ; Concepci Marin [Espagne] | In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson’s disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese‐enhanced magnetic resonance imaging in the 6‐hydroxydopamine rat model |
000353 (2011) |
Carmen Agustín-Pav N [Royaume-Uni] ; John Parkinson [Royaume-Uni] ; Mei-See Man [Royaume-Uni] ; Angela C. Roberts [Royaume-Uni] | Contribution of the amygdala, but not orbitofrontal or medial prefrontal cortices, to the expression of flavour preferences in marmoset monkeys |
000412 (2011) |
Saskia Van Stockum [Nouvelle-Zélande] ; Michael R. Macaskill [Nouvelle-Zélande] ; Daniel Myall [Nouvelle-Zélande] ; Tim J. Anderson [Nouvelle-Zélande] | A perceptual discrimination task abnormally facilitates reflexive saccades in Parkinson’s disease |
000488 (2010) |
Li Rebekah Feng [États-Unis] ; Howard J. Federoff [États-Unis] ; Stefano Vicini [États-Unis] ; Kathleen A. Maguire-Zeiss [États-Unis] | α‐Synuclein mediates alterations in membrane conductance: a potential role for α‐synuclein oligomers in cell vulnerability |
000518 (2010) |
Federica Agosta [Italie] ; Vladimir S. Kosti [Serbie] ; Sebastiano Galantucci [Italie] ; Šarlota Mesaroš [Italie, Serbie] ; Marina Svetel [Serbie] ; Elisabetta Pagani [Italie] ; Elka Stefanova [Serbie] ; Massimo Filippi [Italie] | The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP‐parkinsonism: a VBM‐DARTEL study |
000556 (2010) |
Romulo Fuentes [États-Unis] ; Per Petersson [Suède] ; Miguel A. L. Nicolelis [États-Unis, Brésil] | Restoration of locomotive function in Parkinson’s disease by spinal cord stimulation: mechanistic approach |
000727 (2010) |
Jens Clausen [Allemagne] | Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice |
000766 (2010) |
Ayse Ulusoy [Suède] ; Fabia Febbraro [Danemark] ; Poul H. Jensen [Danemark] ; Deniz Kirik [Suède] ; Marina Romero-Ramos [Suède, Danemark] | Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology |
000785 (2010) |
Esther Florin [Allemagne] ; Joachim Gross [Royaume-Uni] ; Christiane Reck [Allemagne] ; Mohammad Maarouf [Allemagne] ; Alfons Schnitzler [Allemagne] ; Volker Sturm [Allemagne] ; Gereon R. Fink [Allemagne] ; Lars Timmermann [Allemagne] | Causality between local field potentials of the subthalamic nucleus and electromyograms of forearm muscles in Parkinson’s disease |
000912 (2009) |
David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
000918 (2009) |
Alice Nieuwboer [Belgique] ; Sarah Vercruysse [Belgique] ; Peter Feys [Belgique] ; Oron Levin [Belgique] ; Joke Spildooren [Belgique] ; Stephan Swinnen [Belgique] | Upper limb movement interruptions are correlated to freezing of gait in Parkinson’s disease |
000931 (2009) |
Thibaud Lebouvier [France] ; Tanguy Chaumette [France] ; Sébastien Paillusson [France] ; Charles Duyckaerts [France] ; Stanislas Bruley Des Varannes [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France] | The second brain and Parkinson’s disease |
000A15 (2009) |
J. Coste [France] ; L. Ouchchane [France] ; L. Sarry [France] ; P. Derost [France] ; F. Durif [France] ; J. Gabrillargues [France] ; S. Hemm [France] ; J. J. Lemaire [France] | New electrophysiological mapping combined with MRI in parkinsonian’s subthalamic region |
000A21 (2009) |
Naroa Ibarretxe-Bilbao [Espagne] ; Carme Junque [Espagne] ; Eduardo Tolosa [Espagne] ; Maria-Jose Marti [Espagne] ; Francesc Valldeoriola [Espagne] ; Nuria Bargallo [Espagne] ; Mojtaba Zarei [Royaume-Uni] | Neuroanatomical correlates of impaired decision‐making and facial emotion recognition in early Parkinson’s disease |
000A73 (2009) |
Na K. Kim [Corée du Sud] ; Byung H. Choi [Corée du Sud] ; Xian Huang [Corée du Sud] ; Brian J. Snyder [Canada] ; Shefqat Bukhari [Canada] ; Tae-Ho Kong [Corée du Sud] ; Hyeonseon Park [Corée du Sud] ; Hyung C. Park [Corée du Sud] ; So R. Park [Corée du Sud] ; Yoon Ha [Corée du Sud] | Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model |
000B00 (2009) |
Christian Beste [Allemagne] ; Isabel Dziobek [Allemagne] ; Horst Hielscher [Allemagne] ; Rita Willemssen [Allemagne] ; Michael Falkenstein [Allemagne] | Effects of stimulus–response compatibility on inhibitory processes in Parkinson’s disease |
000B01 (2009) |
C. Marin [Espagne] ; E. Aguilar [Espagne] ; G. Mengod [Espagne] ; R. Cortés [Espagne] ; J. A. Obeso [Espagne] | Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats |
000B25 (2009) |
Tultul Nayyar [États-Unis] ; Michael Bubser [États-Unis] ; Marcus C. Ferguson [États-Unis] ; M. Diana Neely [États-Unis] ; J. Shawn Goodwin [États-Unis] ; Thomas J. Montine [États-Unis] ; Ariel Y. Deutch [États-Unis] ; Twum A. Ansah [États-Unis] | Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation |
000B44 (2009) |
Franz Marxreiter [Allemagne] ; Silke Nuber [Allemagne] ; Mahesh Kandasamy [Allemagne] ; Jochen Klucken [Allemagne] ; Robert Aigner [Allemagne] ; Ralf Burgmayer [Allemagne] ; Sebastien Couillard-Despres [Allemagne] ; Olaf Riess [Allemagne] ; Jürgen Winkler [États-Unis, Allemagne] ; Beate Winner [Allemagne] | Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha‐synuclein |
000C57 (2008) |
Ronald L. Klein [États-Unis] ; Robert D. Dayton ; Jason B. Tatom ; Cynthia G. Diaczynsky ; Michael F. Salvatore | Tau expression levels from various adeno‐associated virus vector serotypes produce graded neurodegenerative disease states |
000E30 (2008) |
Darcy Litteljohn [Canada] ; Emily N. Mangano [Canada] ; Shawn Hayley [Canada] | Cyclooxygenase‐2 deficiency modifies the neurochemical effects, motor impairment and co‐morbid anxiety provoked by paraquat administration in mice |
000E58 (2008) |
Meir Plotnik [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Bilateral coordination of walking and freezing of gait in Parkinson’s disease |
000F27 (2007) |
Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie] | Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model |
000F50 (2007) |
M. J. Hurley [Royaume-Uni] ; P. H. Patel [Royaume-Uni] ; M. J. Jackson [Royaume-Uni] ; L. A. Smith [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] | Striatal leucine‐rich repeat kinase 2 mRNA is increased in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned common marmosets (Callithrix jacchus) with l‐3, 4‐dihydroxyphenylalanine methyl ester‐induced dyskinesia |
000F63 (2007) |
Jeffrey M. Hausdorff [Israël, États-Unis] ; Justine Lowenthal [Israël] ; Talia Herman [Israël] ; Leor Gruendlinger [Israël] ; Chava Peretz [Israël] ; Nir Giladi [Israël] | Rhythmic auditory stimulation modulates gait variability in Parkinson's disease |
001004 (2007) |
Hyun Jung Park [Corée du Sud] ; Phil Hyu Lee [Corée du Sud] ; Young Whan Ahn [Corée du Sud] ; Yun Jung Choi [Corée du Sud] ; Gwang Lee [Corée du Sud] ; Da-Yong Lee [Corée du Sud] ; Eun S. Chung [Corée du Sud] ; Byung Kwan Jin [Corée du Sud] | Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action |
001040 (2007) |
Emilie Lacombe ; Carole Carcenac ; Sabrina Boulet ; Claude Feuerstein [France] ; Anne Bertrand ; Annie Poupard ; Marc Savasta [France] | High‐frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l‐3,4‐dihydroxyphenylalanine in dopaminergic denervated rats |
001071 (2007) |
Soon S. Park [États-Unis] ; Emily M. Schulz [États-Unis] ; Daewoo Lee [États-Unis] | Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by α‐synuclein |
001234 (2006) |
Ana I. Rojo [Espagne] ; Celia Montero [Espagne] ; María Salazar [Espagne] ; Ryan M. Close [États-Unis] ; Javier Fernández-Ruiz [Espagne] ; Miguel A. Sánchez-González [Espagne] ; María Rosa De Sagarra [Espagne] ; Vernice Jackson-Lewis [États-Unis] ; Carmen Cavada [Espagne] ; Antonio Cuadrado [Espagne] | Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice |
001254 (2006) |
David W. Anderson [États-Unis] ; Kristin A. Bradbury [États-Unis] ; Jay S. Schneider [États-Unis] | Neuroprotection in Parkinson models varies with toxin administration protocol |
001264 (2006) |
Rossitza Baltadjieva [Israël] ; Nir Giladi [Israël] ; Leor Gruendlinger [Israël] ; Chava Peretz [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease |
001362 (2006) |
Rebecca E. Colebrooke [Royaume-Uni] ; Trevor Humby [Royaume-Uni] ; Patrick J. Lynch [Royaume-Uni] ; Daniel P. Mcgowan [Royaume-Uni] ; Jing Xia [Royaume-Uni] ; Piers C. Emson [Royaume-Uni] | Age‐related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease |
001392 (2005) |
Mahmoud M. Iravani [Royaume-Uni] ; Sergio Costa [Royaume-Uni] ; Ghassan Al-Bargouthy [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Bai-Yun Zeng [Royaume-Uni] ; Mikko Kuoppam Ki [Royaume-Uni] ; Jose A. Obeso [Espagne] ; Peter Jenner [Royaume-Uni] | Unilateral pallidotomy in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets exhibiting levodopa‐induced dyskinesia |
001403 (2005) |
Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann [Canada] ; Lori K. Smith [Canada] ; Karim Fouad [Canada] | The unilateral 6‐OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis |
001406 (2005) |
Mahmoud M. Iravani [Royaume-Uni] ; Clement C. M. Leung [Royaume-Uni] ; Mona Sadeghian [Royaume-Uni] ; Claire O. Haddon [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation |
001416 (2005) |
Pedro Barroso-Chinea [Espagne] ; Ignacio Cruz-Muros [Espagne] ; María S. Aymerich [Espagne] ; Manuel Rodríguez-Díaz [Espagne] ; Domingo Afonso-Oramas [Espagne] ; José L. Lanciego [Espagne] ; Tomás González-Hernández [Espagne] | Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells |
001417 (2005) |
Colum D. Mackinnon [États-Unis] ; Ruth M. Webb [Royaume-Uni] ; Paul Silberstein [Royaume-Uni] ; Steven Tisch [Royaume-Uni] ; Peter Asselman [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] | Stimulation through electrodes implanted near the subthalamic nucleus activates projections to motor areas of cerebral cortex in patients with Parkinson's disease |
001437 (2005) |
Katsumi Tsuchiya [Japon] ; Hisao Tajima [Japon] ; Toyoyasu Kuwae [Japon] ; Takao Takeshima [Japon] ; Toshiya Nakano [Japon] ; Masaharu Tanaka [Japon] ; Katsuyoshi Sunaga [Japon] ; Yoko Fukuhara [Japon] ; Kenji Nakashima [Japon] ; Eisaku Ohama [Japon] ; Hideki Mochizuki [Japon] ; Yoshikuni Mizuno [Japon] ; Nobuo Katsube [Japon] ; Ryoichi Ishitani [Japon] | Pro‐apoptotic protein glyceraldehyde‐3‐phosphate dehydrogenase promotes the formation of Lewy body‐like inclusions |
001471 (2005) |
Catharine A. Winstanley [Royaume-Uni] ; Christelle Baunez [France] ; David E. H. Theobald [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] | Lesions to the subthalamic nucleus decrease impulsive choice but impair autoshaping in rats: the importance of the basal ganglia in Pavlovian conditioning and impulse control |
001472 (2005) |
Eilís Dowd [Royaume-Uni] ; Christelle Monville [Royaume-Uni] ; Eduardo M. Torres [Royaume-Uni] ; Liang-Fong Wong [Royaume-Uni] ; Mimoun Azzouz [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Stephen B. Dunnett [Royaume-Uni] | Lentivector‐mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model |
001478 (2005) |
Joanna Iczkiewicz [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat |
001503 (2005) |
Galit Yogev [Israël] ; Nir Giladi [Israël] ; Chava Peretz [Israël] ; Shmuel Springer [Israël] ; Ely S. Simon [États-Unis] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding? |
001506 (2005) |
Fang Du [République populaire de Chine] ; Rui Li [République populaire de Chine] ; Yuangui Huang [République populaire de Chine] ; Xuping Li [République populaire de Chine] ; Weidong Le [République populaire de Chine] | Dopamine D3 receptor‐preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons |
001507 (2005) |
N. L. W. Keijsers [Pays-Bas] ; M. A. Admiraal [Pays-Bas] ; A. R. Cools [Pays-Bas] ; B. R. Bloem [Pays-Bas] ; C. C. A. M. Gielen [Pays-Bas] | Differential progression of proprioceptive and visual information processing deficits in Parkinson's disease |
001545 (2005) |
Mahmoud M. Iravani [Royaume-Uni] ; Emilie Syed [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Louisa C. Johnston [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets |
001549 (2005) |
P. M. Carvey [États-Unis] ; C. H. Zhao [États-Unis] ; B. Hendey [États-Unis] ; H. Lum [États-Unis] ; J. Trachtenberg [États-Unis] ; B. S. Desai [États-Unis] ; J. Snyder [États-Unis] ; Y. G. Zhu [États-Unis] ; Z. D. Ling [États-Unis] | 6‐Hydroxydopamine‐induced alterations in blood–brain barrier permeability |
001602 (2004) |
Elanor C. Hinton [Royaume-Uni] ; John A. Parkinson [Royaume-Uni] ; Anthony J. Holland [Royaume-Uni] ; F. Sergio Arana [Royaume-Uni] ; Angela C. Roberts [Royaume-Uni] ; Adrian M. Owen [Royaume-Uni] | Neural contributions to the motivational control of appetite in humans |